<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-97358" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Clotrimazole</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khatter</surname>
            <given-names>Neil J.</given-names>
          </name>
          <aff>Oakland University William Beaumont School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khan</surname>
            <given-names>Moien AB</given-names>
          </name>
          <aff>United Arab Emirates University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Neil Khatter declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Moien AB Khan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-97358.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Clotrimazole is a medication used in the management and treatment of fungal infections. It is in the imidazole class of drugs. This activity outlines the indications, action, and contraindications for clotrimazole as a valuable agent in the treatment of fungal infections.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the mechanism of action of clotrimazole.</p></list-item><list-item><p>Describe the adverse effects of clotrimazole.</p></list-item><list-item><p>Review the appropriate monitoring for toxicity of clotrimazole.</p></list-item><list-item><p>Discuss interprofessional team strategies for improving care coordination and communication to advance appropriate antifungal treatment, identify warning signs of serious illness, and improve health outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=97358&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=97358">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-97358.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Clotrimazole is a synthetic imidazole with a broad spectrum of antimycotic activity.<xref ref-type="bibr" rid="article-97358.r1">[1]</xref>&#x000a0;Clotrimazole is an FDA-approved drug to treat oral candidiasis, vaginal candidiasis, and dermatomycoses. Clotrimazole is effective in the treatment of skin infections such as athlete's foot, jock itch, ringworm, pityriasis versicolor, intertrigo, and erythrasma.<xref ref-type="bibr" rid="article-97358.r2">[2]</xref><xref ref-type="bibr" rid="article-97358.r3">[3]</xref></p>
        <p>In addition,&#x000a0;clotrimazole&#x000a0;has some&#x000a0;activity against certain gram-positive bacteria, and at very high concentrations, has activity against&#x000a0;Trichomonas&#x000a0;spp.<xref ref-type="bibr" rid="article-97358.r4">[4]</xref> In adults and children older than 12 years, the FDA has approved the use of clotrimazole in combination with betamethasone propionate (corticosteroid) for the topical treatment of inflammatory tinea due to <italic toggle="yes">Epidermophyton floccosum</italic> and <italic toggle="yes">Trichophyton</italic>. However, caution should be exercised, as the use of such combinations can aggravate fungal infections.<xref ref-type="bibr" rid="article-97358.r5">[5]</xref></p>
      </sec>
      <sec id="article-97358.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Clotrimazole exerts its action primarily by damaging the permeability barrier in the fungal cytoplasmic membrane.<xref ref-type="bibr" rid="article-97358.r6">[6]</xref>&#x000a0;Clotrimazole thereby inhibits the biosynthesis of ergosterol in a concentration-dependent manner by inhibiting the demethylation of 14 alpha lanosterol.<xref ref-type="bibr" rid="article-97358.r7">[7]</xref>&#x000a0;When ergosterol synthesis becomes inhibited, the cell can no longer construct an intact and functional cell membrane.<xref ref-type="bibr" rid="article-97358.r8">[8]</xref>&#x000a0;Ergosterol also directly promotes the growth of fungal cells in a hormone-like fashion; therefore, the rapid onset of the above events leads to a dose-dependent inhibition of fungal growth.</p>
        <p>Though clotrimazole exerts its anti-fungal action by decreasing ergosterol biosynthesis, clotrimazole exerts other pharmacological actions. These include the inhibition of sarcoplasmic reticulum ca2+ ATPase, depletion of intracellular calcium, and blocking of calcium-dependent potassium channels and voltage-dependent calcium channels.<xref ref-type="bibr" rid="article-97358.r9">[9]</xref><xref ref-type="bibr" rid="article-97358.r10">[10]</xref>&#x000a0;Such action of clotrimazole on different cell targets accounts for other effects of this drug that are separate from its antimycotic activities.<xref ref-type="bibr" rid="article-97358.r1">[1]</xref></p>
      </sec>
      <sec id="article-97358.s4" sec-type="Administration">
        <title>Administration</title>
        <p>Clotrimazole is available as topical lotions, powders, oral lozenges, and vaginal inserts/tablets under various tradenames approved by the FDA.</p>
        <p>
<bold>Oral Administration of Other Oral Formulations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Transmucosal administration</p>
          </list-item>
          <list-item>
            <p>Patients should slowly dissolve troches in the mouth, do not chew.</p>
          </list-item>
        </list>
        <p>
<bold>Topical Administration Cream/Ointment/Lotion Formulations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Rub cream or solution gently into the cleansed affected skin.</p>
          </list-item>
          <list-item>
            <p>Topical preparations should not be used in the eye; or used intravaginally.</p>
          </list-item>
        </list>
        <p>
<bold>Intravaginal Administration</bold>
</p>
        <p>Intravaginal application is only for those clotrimazole products labeled for intravaginal use. Some commercially available preparations contain both intravaginal tablets and vaginal cream in a combination package. &#x000a0;The intravaginal cream may be applied externally to the affected area (vulva) to relieve itching and discomfort.</p>
        <p>Use a special applicator supplied by the manufacturer.</p>
        <p>Instruct patients on proper administration and treatment courses.</p>
        <p>Patients should not use tampons, douches, or spermicides during treatment. The patient should also receive instruction to abstain from sexual activity during treatment. Vaginal clotrimazole products may cause damage to condoms, diaphragms, and cervical caps and cause them to fail.</p>
        <p>
<bold>Vaginal Dosage (vaginal cream) Adult Females</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>One applicatorful of 1% cream (50 mg) vaginally for seven days or one applicatorful of 2% cream (100 mg) vaginally for three days, applied at bedtime.</p>
          </list-item>
          <list-item>
            <p>External application of the cream may also is an option if there are extra-vaginal symptoms. Guidelines recommend treatment for seven days for pregnant patients&#x000a0;and 7 to 14 days for immunocompromised patients.<xref ref-type="bibr" rid="article-97358.r11">[11]</xref><xref ref-type="bibr" rid="article-97358.r12">[12]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Adolescent Females 12 to 17 years</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Apply one applicatorful of 1% cream (50 mg) vaginally for seven days or one applicatorful of 2% cream (100 mg) vaginally at bedtime for three days. External application of the cream may also are an option if there are extra-vaginal symptoms. Guidelines recommend treatment for seven days for pregnant patients and 7 to 14 days for immunocompromised patients.</p>
          </list-item>
        </list>
        <p>
<bold>For the Treatment of Oropharyngeal Candidiasis (thrush) Transmucosal Dosage</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>10 mg PO 5 times daily for 7 to 14 days<xref ref-type="bibr" rid="article-97358.r13">[13]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Children and Adolescents 3 to 17 years</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>10 mg PO 5 times daily for 7 to 14 days</p>
          </list-item>
        </list>
        <p>
<bold>For the Treatment of Tinea Versicolor Topical</bold>
</p>
        <p>
<bold>Adults</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Apply to the affected skin and surrounding areas twice daily, both morning and evening.</p>
          </list-item>
        </list>
        <p>
<bold>Children and Adolescents</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Apply to the affected skin and surrounding areas twice daily, both morning and evening.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-97358.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>The adverse effects of oral formulation include itching, nausea, and vomiting. More than 10% of patients using the oral formulation may have abnormal liver function tests. For this reason, liver function tests should have periodic monitoring when taking oral clotrimazole (troche).&#x000a0;When using clotrimazole to treat vulvovaginal candidiasis, &#x0003c;10% of patients have a vulvar or vaginal burning sensation. Other side effects include rash, hives, blisters, burning, itching, peeling, redness, swelling, pain, or other signs of skin irritation.<xref ref-type="bibr" rid="article-97358.r14">[14]</xref>&#x000a0;For topical formulations, it should be used externally and discontinued if irritation or sensitivity develops at the administration site.</p>
      </sec>
      <sec id="article-97358.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>
<bold>Onychomycosis</bold>
</p>
        <p>Topical clotrimazole is not effective for onychomycosis. Therefore, fungal nail infections usually require treatment with an oral (systemic) antifungal drug.</p>
        <p>
<bold>Pregnancy</bold>
</p>
        <p>Clotrimazole demonstrates poor absorption after dermal or intravaginal administration. Only topical preparations&#x000a0;are recommended in pregnancy.<xref ref-type="bibr" rid="article-97358.r15">[15]</xref> There are inadequate well-controlled human studies with the use of topical or intravaginal clotrimazole during the first trimester of pregnancy clotrimazole should only be used if indicated.<xref ref-type="bibr" rid="article-97358.r16">[16]</xref> However, clinical trials showed intravaginal clotrimazole to be safe in clinical trials during the second and the third trimester of pregnancy and are recommended for use.<xref ref-type="bibr" rid="article-97358.r17">[17]</xref><xref ref-type="bibr" rid="article-97358.r12">[12]</xref>&#x000a0;</p>
        <p>Clotrimazole is not known to cross the placenta.<xref ref-type="bibr" rid="article-97358.r11">[11]</xref> FDA classifies clotrimazole as a class C drug in pregnancy risk classification. There are no adequate, well-controlled studies for oral clotrimazole in pregnant women. There have been no teratogenic effects demonstrated after clotrimazole therapy in pregnancy.<xref ref-type="bibr" rid="article-97358.r17">[17]</xref>&#x000a0;In animal studies with dosing up to 200 times the human dose, doses of 100 times the adult human dose have been embryotoxic in rats and mice. There are well-controlled studies in humans; hence the use of oral clotrimazole lozenges during pregnancy should only be an option if the potential benefit justifies the potential risk to the fetus.</p>
        <p>
<bold>Breast-feeding</bold>
</p>
        <p>The use of clotrimazole during breastfeeding has not been studied. No data is available about the excretion of clotrimazole in breast milk. Topical clotrimazole poses little risk to nursing infants as topical clotrimazole is not expected to result in significant maternal absorption.<xref ref-type="bibr" rid="article-97358.r18">[18]</xref> Instruct mothers not to apply clotrimazole topically to the breast during times of breastfeeding. The oral troches should be used only when needed, as this may be systemically absorbed. Report to the FDA if a breastfeeding infant experiences any adverse effects.</p>
        <p>
<bold>Contraceptive Devices, Menstruation</bold>
</p>
        <p>Patients should abstain from sexual intercourse during the treatment course. With intravaginal clotrimazole preparations, contraceptive failures can occur during the treatment due to the damage of contraceptive devices such as diaphragms, condoms, and cervical caps. In addition, tampon use is not advisable while using clotrimazole during menstruation.</p>
        <p>
<bold>Azole Antifungals Hypersensitivity</bold>
</p>
        <p>Patients with azole antifungals hypersensitivity should avoid using clotrimazole. Hypersensitivity reactions commonly occur due to the components in the formulation present in different clotrimazole preparations.</p>
        <p>
<bold>Ocular Exposure, Ophthalmic Administration</bold>
</p>
        <p>If eye contact with clotrimazole occurs, treat immediately by flushing the affected eye with cool, clean water. Contact an ophthalmologist if eye irritation persists.</p>
        <p>
<bold>Drug-drug Interactions </bold>
</p>
        <p>Clotrimazole therapy may result in a significant rise in tacrolimus levels, leading to tacrolimus-associated toxicities. Hence caution should be exercised.<xref ref-type="bibr" rid="article-97358.r19">[19]</xref></p>
      </sec>
      <sec id="article-97358.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>Clotrimazole is not for systemic administration; it is administered via oral/transmucosal lozenges (troches), either topically or intravaginally. Small quantities absorbed are metabolized in the liver and excreted in the bile.</p>
        <p>
<bold>Oral Route</bold>
</p>
        <p>Transmucosal Route - clotrimazole oral lozenges are used for local treatment and are not significantly bioavailable. Concentrations persisting in saliva appear to be due to clotrimazole binding to the oral mucosa.</p>
        <p>
<bold>Topical Route</bold>
</p>
        <p>There is minimal systemic absorption following topical application of clotrimazole.</p>
        <p>
<bold>Other Routes</bold>
</p>
        <p>Intravaginal Route - roughly 5&#x000a0;to 10% of clotrimazole undergoes absorption following vaginal use. Therefore, fungicidal concentrations can persist in the vagina for up to 3 days after application.</p>
      </sec>
      <sec id="article-97358.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>When&#x000a0;clotrimazole is applied locally and topically, toxic effects such as pelvic cramps, hives, skin rash, occasional headache, itching, and irritation of the vulva and vagina may be observed. Stop the medication if there are any adverse effects.</p>
      </sec>
      <sec id="article-97358.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>With any atypical symptoms, careful evaluation and reassessment should take place before prescribing or dispensing clotrimazole. Vaginal candidal infections can co-exist with other sexually transmitted infections. Hence symptoms such as foul-smelling vaginal discharge, abdominal pain, or fever higher than 100 degrees F may indicate another vaginal infection or pelvic inflammatory disease.&#x000a0;</p>
        <p>The clinician or the nurse practitioner&#x000a0;should also counsel the patient on the importance of reading labels to understand the possible side effects and avoid drug-related toxicities due to&#x000a0;overdosing.&#x000a0;Pharmacists should also check for any associated drug interactions and inform the prescriber and the patient of any concerns. Clinicians, nurses, physician assistants, and pharmacists should cooperate with interprofessional team strategies&#x000a0;to advance appropriate antifungal treatment, identify warning signs of serious illness, and improve health outcomes.&#x000a0;[level 5]</p>
      </sec>
      <sec id="article-97358.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=97358&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=97358">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/97358/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=97358">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-97358.s11">
        <title>References</title>
        <ref id="article-97358.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crowley</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Gallagher</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Clotrimazole as a pharmaceutical: past, present and future.</article-title>
            <source>J Appl Microbiol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>117</volume>
            <issue>3</issue>
            <fpage>611</fpage>
            <page-range>611-7</page-range>
            <pub-id pub-id-type="pmid">24863842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woo</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Somayaji</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Haber</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Management of Cutaneous Tinea Infections.</article-title>
            <source>Adv Skin Wound Care</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>8</issue>
            <fpage>350</fpage>
            <page-range>350-357</page-range>
            <pub-id pub-id-type="pmid">31335433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalra</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Kinney</surname>
                <given-names>BS</given-names>
              </name>
            </person-group>
            <article-title>Intertrigo and secondary skin infections.</article-title>
            <source>Am Fam Physician</source>
            <year>2014</year>
            <month>Apr</month>
            <day>01</day>
            <volume>89</volume>
            <issue>7</issue>
            <fpage>569</fpage>
            <page-range>569-73</page-range>
            <pub-id pub-id-type="pmid">24695603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sawyer</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Brogden</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Pinder</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Speight</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Avery</surname>
              </name>
            </person-group>
            <article-title>Clotrimazole: a review of its antifungal activity and therapeutic efficacy.</article-title>
            <source>Drugs</source>
            <year>1975</year>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>424</fpage>
            <page-range>424-47</page-range>
            <pub-id pub-id-type="pmid">1097234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ely</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seabury Stone</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of tinea infections.</article-title>
            <source>Am Fam Physician</source>
            <year>2014</year>
            <month>Nov</month>
            <day>15</day>
            <volume>90</volume>
            <issue>10</issue>
            <fpage>702</fpage>
            <page-range>702-10</page-range>
            <pub-id pub-id-type="pmid">25403034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haller</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Mode of action of clotrimazole: implications for therapy.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1985</year>
            <month>Aug</month>
            <day>01</day>
            <volume>152</volume>
            <issue>7 Pt 2</issue>
            <fpage>939</fpage>
            <page-range>939-44</page-range>
            <pub-id pub-id-type="pmid">3895959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hitchcock</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Dickinson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans.</article-title>
            <source>Biochem J</source>
            <year>1990</year>
            <month>Mar</month>
            <day>01</day>
            <volume>266</volume>
            <issue>2</issue>
            <fpage>475</fpage>
            <page-range>475-80</page-range>
            <pub-id pub-id-type="pmid">2180400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghannoum</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>LB</given-names>
              </name>
            </person-group>
            <article-title>Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>501</fpage>
            <page-range>501-17</page-range>
            <pub-id pub-id-type="pmid">10515900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartolommei</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tadini-Buoninsegni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hua</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moncelli</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Inesi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guidelli</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Clotrimazole inhibits the Ca2+-ATPase (SERCA) by interfering with Ca2+ binding and favoring the E2 conformation.</article-title>
            <source>J Biol Chem</source>
            <year>2006</year>
            <month>Apr</month>
            <day>07</day>
            <volume>281</volume>
            <issue>14</issue>
            <fpage>9547</fpage>
            <page-range>9547-51</page-range>
            <pub-id pub-id-type="pmid">16452481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jan</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Chiang</surname>
                <given-names>HT</given-names>
              </name>
            </person-group>
            <article-title>Novel effects of clotrimazole on Ca2+ signaling in Madin Darby canine kidney cells.</article-title>
            <source>Life Sci</source>
            <year>2000</year>
            <volume>66</volume>
            <issue>23</issue>
            <fpage>2289</fpage>
            <page-range>2289-96</page-range>
            <pub-id pub-id-type="pmid">10855950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Use of antifungal drugs in pregnancy: a focus on safety.</article-title>
            <source>Drug Saf</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-85</page-range>
            <pub-id pub-id-type="pmid">10915033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <article-title>Sexually Transmitted Diseases: Summary of 2015 CDC Treatment Guidelines.</article-title>
            <source>J Miss State Med Assoc</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>56</volume>
            <issue>12</issue>
            <fpage>372</fpage>
            <page-range>372-5</page-range>
            <pub-id pub-id-type="pmid">26975162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pappas</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Kauffman</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Andes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Clancy</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Marr</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ostrosky-Zeichner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reboli</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Schuster</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Vazquez</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Zaoutis</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Feb</month>
            <day>15</day>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>e1</fpage>
            <page-range>e1-50</page-range>
            <pub-id pub-id-type="pmid">26679628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jelen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tennstedt</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Contact dermatitis from topical imidazole antifungals: 15 new cases.</article-title>
            <source>Contact Dermatitis</source>
            <year>1989</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <page-range>6-11</page-range>
            <pub-id pub-id-type="pmid">2530045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Schalkwyk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yudin</surname>
                <given-names>MH</given-names>
              </name>
              <collab>INFECTIOUS DISEASE COMMITTEE</collab>
            </person-group>
            <article-title>Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>266</fpage>
            <page-range>266-274</page-range>
            <pub-id pub-id-type="pmid">26001874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Black</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Over-the-counter medications in pregnancy.</article-title>
            <source>Am Fam Physician</source>
            <year>2003</year>
            <month>Jun</month>
            <day>15</day>
            <volume>67</volume>
            <issue>12</issue>
            <fpage>2517</fpage>
            <page-range>2517-24</page-range>
            <pub-id pub-id-type="pmid">12825840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czeizel</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>T&#x000f3;th</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rockenbauer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>No teratogenic effect after clotrimazole therapy during pregnancy.</article-title>
            <source>Epidemiology</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>437</fpage>
            <page-range>437-40</page-range>
            <pub-id pub-id-type="pmid">10401880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spencer</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Barnhart</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Medications in the breast-feeding mother.</article-title>
            <source>Am Fam Physician</source>
            <year>2001</year>
            <month>Jul</month>
            <day>01</day>
            <volume>64</volume>
            <issue>1</issue>
            <fpage>119</fpage>
            <page-range>119-26</page-range>
            <pub-id pub-id-type="pmid">11456429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-97358.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasquez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pollak</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Benedetti</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients.</article-title>
            <source>Clin Transplant</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-9</page-range>
            <pub-id pub-id-type="pmid">11264634</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
